Study startup (SSU) refers to the set of activities required to prepare a clinical trial for initiation at a research site, from initial feasibility through site activation.
SSU encompasses a range of coordinated processes, including site selection, regulatory document collection, contract and budget negotiation, IRB submission and approval, and operational readiness. Timelines can vary significantly depending on study complexity, site experience, and alignment across sponsors, CROs, and institutional stakeholders.
Delays in SSU are often driven by incomplete documentation, prolonged contract negotiations, or misalignment between regulatory and operational workflows. A well-managed SSU process—supported by clear communication, standardized documentation, and proactive oversight—can accelerate activation timelines and position sites for efficient, compliant study conduct.